More importantly, gene silencing of PRC1 could reduce the expression of β-catenin, cyclin D2, c-Myc and c-Jun in Wnt/β-catenin pathway in NSCLC cell lines (Zhan et al., 2017). This evidence concerns the gene MYC and non-small cell lung carcinoma.